Volkmar Falk
Declaration of interest
| Function | Company |
|---|---|
| Honorarium | Edwards Lifesciences |
| Honorarium | Medtronic |
| Grants/research support | Philips |
| Consultant | Valtech |
Latest contributions
How to treat my patient with primary mitral regurgitation?
20 Nov 2023 – From PCR London Valves 2023
In this session, study the different cases of primary mitral regurgitation in detail, with diagrams, videos and even recommendations, to find out when to opt for replacement rather than repair, how to better manage transcatheter mitral replacement, and how to get to grips with endoscopic mitral...
Mitral annular calcification - From diagnosis to treatment
29 Nov 2022 – From PCR London Valves 2022
Focus on mitral annular calcification: from diagnosis to treatment, learn more about the prevalence and clinical importance of MAC, understand the challenges of different therapeutic approaches and discover the current results and perspectives on transcatheter mitral valve implantation in patients with MAC.
A case-based tailored approach to the treatment of mitral valve disease: the Heart Team ring
28 Nov 2022 – From PCR London Valves 2022
Join an advanced Heart Team in a real case discussion to understand what "mitral valve complexity" really means and to learn how to optimise selection between repair and replacement options.
Transcatheter primary mitral regurgitation repair and tricuspid replacement - LIVE case
28 Nov 2022 – From PCR London Valves 2022
- Part 1: Primary MR repair (recorded case)
An 89-year-old male with atrial fibrillation, severe primary MR (prolapse A1-A2) with a preserved LV function. The operators implant 1 Pascal ACE, on general anaesthesia, guided by TEE. - Part 2: Tricuspid valve in valve (Live case)
A 52-year-old female, with diabetes and...
How to deal with residual or recurrent mitral regurgitation after failed surgical or transcatheter repair
28 Nov 2022 – From PCR London Valves 2022
Consul this session to learn more about the available treatment options after failed mitral surgical or transcatheter procedures, the factors that increase the likelihood of residual/recurrent mitral regurgitation, and more!
Primary mitral regurgitation: treatment options when the anatomy is simple
27 Nov 2022 – From PCR London Valves 2022
Consult this session to learn about the different technical aspects and limitations for both surgical and catheter-based techniques and to understand the design and implications of two current RCTs comparing interventional and surgical techniques in patients with primary mitral regurgitation.
Revascularisation for Ischemic heart failure: is PCI as good as CABG?
27 Sep 2022
Pamela Gatto interviews Volkmar Falk, Cardiovascular Surgeon, and Dejan Milasinovic, Interventional Cardiologist, to get their perspective about the results of the REVIVED-BCIS2 trial.
The 3 questions are:
- What were your first thoughts and feelings when the findings from REVIVED were presented at ESC 2022?
- In STICH(es), CABG had a...
Innovations in surgical and transcatheter mitral valve intervention
23 Nov 2020 – From PCR Valves e-Course 2020
Watch this session if you want to hear more about the latest advances in surgical and transcatheter approaches to mitral valve disease and to appreciate the anatomical, clinical and engineering challenges associated with future development.
This session was originally presented during PCR Valves e-Course 2020.
Primary mitral regurgitation in 2019: how to deliver the best treatment to our patients
05 Dec 2019 – From PCR London Valves 2019
Consult this session on primary mitral regurgitation to learn more about the current practice and advanced surgical and transcatheter techniques, and discover key tips and tricks that will improve procedural outcomes in your everyday clinical practice.
Complications of surgical and transcatheter valve interventions: the case that taught me most
19 Nov 2019 – From PCR London Valves 2019
Consult this session on the complications of surgical and transcatheter valve interventions to learn tips and tricks from high-volume experienced operators, and to discover techniques for an effective prevention and management of life-threatening complications.
Heart Team 2.0 in action: TAVI or SAVR in younger lower-risk patients?
18 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI vs SAVR in younger lower-risk patients to learn all about the outcomes of various recent trials and how to translate them into your clinical practice, thanks to a selection of challenging cases involving bicuspid aortic valve disease, small aortic annulus, and complex...
Mitral regurgitation: a comprehensive patient-based approach
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about the pathophysiology of mitral regurgitation, and discover its implications for device design, selection and durability, which imaging modality is the most relevant to clinical decision-making, and how Heart Team working can provide the best treatment option for complex patients.
